Marco Mirani

Thyrotoxicosis in patients with COVID-19: the THYRCOV study

Andrea Lania, Maria Teresa Sandri, Miriam Cellini et al. · European Journal of Endocrinology · 2020 · 357 citations · Full text

Sitagliptin Treatment at the Time of Hospitalization Was Associated With Reduced Mortality in Patients With Type 2 Diabetes and COVID-19: A Multicenter, Case-Control, Retrospective, Observational Study

Sebastiano Bruno Solerte, Francesca D’Addio, Roberto Trevisan et al. · Diabetes Care · 2020 · 242 citations · Full text

HIV-1 Protein Vpr Suppresses IL-12 Production from Human Monocytes by Enhancing Glucocorticoid Action: Potential Implications of Vpr Coactivator Activity for the Innate and Cellular Immunity Deficits Observed in HIV-1 Infection

Marco Mirani, Ilia J. Elenkov, Simona Volpi et al. · The Journal of Immunology · 2002 · 90 citations · Full text

Immunology, Innate Immunity, Glucocorticoid +17

Weight change and glycemic control in type 2 diabetes patients during COVID-19 pandemic: the lockdown effect

Emilia Biamonte, Francesco Pegoraro, Flaminia Carrone et al. · Endocrine · 2021 · 83 citations · Full text

Obesity, Metabolic Syndrome, Diabetes Management +11

SGLT2-inhibitors are effective and safe in the elderly: The SOLD study

Maria Elena Lunati, Vincenzo Cimino, Alessandra Gandolfi et al. · Pharmacological Research · 2022 · 64 citations · Full text

Translational Medicine, Aging, Clinical Therapeutic +8